Article 5
1
The competent authority of a Member State may decide to allow the use of vaccines against bluetongue provided that:
a
such decision is based on the result of a specific risk assessment carried out by the competent authority;
b
the Commission is informed before such vaccination is carried out.
2
Whenever live attenuated vaccines are used, Member States shall ensure that the competent authority demarcates:
a
a protection zone, consisting of at least the vaccination area;
b
a surveillance zone, consisting of a part of the Union territory with a depth of at least 50 kilometres extending beyond the limits of the protection zone.
Substituted by Directive 2012/5/EU of the European Parliament and of the Council of 14 March 2012 amending Council Directive 2000/75/EC as regards vaccination against bluetongue.